Stockscreener 앱 받기
9.54
7.47%
-0.77
전일 마감가:
$10.31
열려 있는:
$10.3
하루 거래량:
54,096
Relative Volume:
0.77
시가총액:
$17.97M
수익:
-
순이익/손실:
$-26.56M
주가수익비율:
-0.2157
EPS:
-44.2199
순현금흐름:
$-28.59M
1주 성능:
-16.24%
1개월 성능:
-5.64%
6개월 성능:
+170.25%
1년 성능:
-3.81%
1일 변동 폭
$9.54
$10.31
1주일 범위
$9.54
$13.09
52주 변동 폭
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
BCTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
9.54 | 19.42M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
Rally Mode: What insider trading reveals about BriaCell Therapeutics Corp stockIPO Watch & Comprehensive Market Scan Insights - moha.gov.vn
(BCT) Trading Performance and Risk Management (BCT:CA) - news.stocktradersdaily.com
BriaCellModel Bria-IMT and Bria-OTSDestroy Cancer Cells - Environmental XPRT
BriaCell reports positive data for breast cancer immunotherapy By Investing.com - Investing.com Nigeria
BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposiu - GuruFocus
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell’s Bria-IMT Shows Promising Results in Metastatic Breast Cancer Trials - TipRanks
BriaCell reports positive data for breast cancer immunotherapy - Investing.com India
(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell (BCTX) Progresses with Phase 3 Study in Metastatic Brea - GuruFocus
BriaCell’s Phase 3 Study on Track for 2026 Data Readout - TipRanks
BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - Investing News Network
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - The Manila Times
Movement Recap: Will BriaCell Therapeutics Corp Equity Warrant stock outperform Dow Jones indexJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - moha.gov.vn
BriaCell Therapeutics (BCTXZ) Stock Analysis Report | Financials & Insights - Benzinga
BriaCell Therapeutics : Investor Presentation (1Dec2025 Investor Presentation) - marketscreener.com
Will BriaCell Therapeutics Corp. Equity Warrant stock outperform Dow Jones indexQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
BriaCell to present positive breast cancer therapy data at SABCS By Investing.com - Investing.com Australia
BriaCell Therapeutics (BCTXW) Stock Analysis Report | Financials & Insights - Benzinga
BriaCell Unveils Promising Clinical Data at 2025 SABCS - TipRanks
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell (BCTX) Shares Positive Clinical Results Ahead of 2025 S - GuruFocus
BriaCell to present positive breast cancer therapy data at SABCS - Investing.com
Can BriaCell Therapeutics Corp. stock hit analyst price targetsMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
(BCT) Strategic Investment Report (BCT:CA) - news.stocktradersdaily.com
Bicara Therapeutics (BCTX) Releases Promising Early Data from Ca - GuruFocus
BriaCell files subsidiary financials and analysis with Canadian regulators By Investing.com - Investing.com Nigeria
BriaCell files subsidiary financials and analysis with Canadian regulators - Investing.com
BriaCell Therapeutics Corp Subsidiary Files Financial Statements - TradingView
(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com
What analysts say about BriaCell Therapeutics Corp stockEquity Performance Review & Fast Growing Portfolio Trading - earlytimes.in
BCTXZ Insider Trading - Quiver Quantitative
BriaCell Therapeutics Corp. (BCTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BriaCell Therapeutics to Present Promising Clinical Data at SABCS 2025 - The Globe and Mail
BriaCell to present positive cancer treatment data at breast cancer symposium By Investing.com - Investing.com Nigeria
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell to present positive cancer treatment data at breast cancer symposium - Investing.com
BriaCell Therapeutics Brief: Says to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS 2025 - marketscreener.com
How to Take Advantage of moves in (BCT) (BCT:CA) - news.stocktradersdaily.com
BriaCell Expands Phase 3 Study in Metastatic Breast Cancer - MSN
What analysts say about BriaCell Therapeutics Corp Equity Warrant stockDividend Stability Analysis & Exceptional Capital Trading - earlytimes.in
BriaCell to Present Key Clinical Data at SABCS 2025 - MSN
BriaCell and Receptor.AI Partner on AI- driven Small Molecule Cancer Therapeutics - MarketScreener
BriaCell (BCTX) Partners with Receptor.AI for Innovative Cancer Drug Development - GuruFocus
Briacell and Receptor.AI to collaborate on AI driven small molecule cancer therapeutics - MarketScreener
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):